For research use only. Not for therapeutic Use.
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
| Catalog Number | I047460 |
| Purity | ≥95% |
| Reference | [1] Carneiro BA, et al. Journal of Clinical Oncology 38, no. 15_suppl |
